NASDAQ (USD): Protagonist Therapeutics, Inc. (PTGX)
Last Price
38.96
Today's Change
-0.55 (1.39%)
Day's Change
38.50 - 39.65
Trading Volume
454,177
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US New-home Sales Rebound in November After Storm-stricken Month
2
Orders for US Business Equipment Rise by Most in Over a Year
3
Biden Launches New US Trade Probe Into Legacy Chinese Chips
4
Google to Fight Japan’s Claims That It Hobbles Rivals in Search
5
Musk Makes ‘overstaffed’ US Fed Target in Quest for Efficiency
#
Stock
Score
AAPL
Apple Inc.
INTZ
Intrusion Inc.
952
ZCAR
Zoomcar Holdings, Inc.
BABA
Alibaba Group Holding Limited
809
AGN
714
6
SOXL
Direxion Daily Semiconductor Bull 3X Shares
7
SCHD
Schwab U.S. Dividend Equity ETF
8
PLTR
Palantir Technologies Inc.
571
9
NOK
Nokia Oyj
476
10
VTV
Vanguard Value Index Fund
Last
Change
Volume
AILE
0.593
+0.432
561,119,346
GTI
1.01
+0.672
395,891,967
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
RGTI
17.06
+1.62
303,147,005
XTIA
0.04
254,812,634
QSI
3.58
+1.43
252,601,842
UWT
0.164
-0.002
244,137,454
AGIL
0.197
+0.114
206,404,986
LYLT
0.218
204,480,452
RTLA
209.90
+74.87
0
ACSG
33.28
+33.28
99,050
EMSA
140.77
+30.77
EMLB
80.80
+30.30
NOVVU
41.00
+28.85
17,976
NOVV
37.00
+23.46
205,220
EDTX
63.24
+20.01
603,885
YNDX
18.94
+18.94
EDTXU
57.22
+18.22
1,071
ASPAU
28.99
+17.77
5,758
BRK-A
684,908.48
-2,691.50
1,254
MELI
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NOW
643.29
-87.83
5,025,012
NVDA
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....